Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H15FIN3O3S |
InChIKeyAOKQJWYNQIKPID-UHFFFAOYSA-N |
CAS Registry2847094-97-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 11 Oct 2022 |